| Pharma pathway |
|
pharmapathway.com |
1955 |
94 |
| Phil Taylor |
|
pharmaphorum.com |
1031 |
18.6K |
| Zachary Brennan |
|
endpts.com |
522 |
10.9K |
| Amber Tong |
|
endpts.com |
409 |
10.9K |
| Nicole DeFeudis |
|
endpts.com |
391 |
10.9K |
| Max Gelman |
|
endpts.com |
384 |
10.9K |
| Paul Schloesser |
|
endpts.com |
375 |
10.9K |
| Vishnu Priyan |
|
pharmaceutical-technology.com |
366 |
590 |
| Josh Sullivan |
|
endpts.com |
356 |
10.9K |
| John Carroll |
|
endpts.com |
354 |
10.9K |
| Beth Snyder Bulik |
|
endpts.com |
266 |
10.9K |
| vishnupriyan |
|
pharmaceutical-technology.com |
240 |
590 |
| Tyler Patchen |
|
endpts.com |
192 |
10.9K |
| Kyle LaHucik |
|
endpts.com |
180 |
10.9K |
| Ned Pagliarulo |
|
biopharmadive.com |
177 |
9.8K |
| Kyle Blankenship |
|
endpts.com |
174 |
10.9K |
| GlobalData Healthcare |
|
pharmaceutical-technology.com |
163 |
590 |
| mike.hammerton@pharmaphorum.com |
|
pharmaphorum.com |
156 |
18.6K |
| Paul Dennis |
|
pharmaceutical-technology.com |
153 |
590 |
| Jason Mast |
|
endpts.com |
134 |
10.9K |
| Vasanthi Vara |
|
pharmaceutical-technology.com |
129 |
590 |
| Jonathan Gardner |
|
biopharmadive.com |
119 |
9.8K |
| Ben Fidler |
|
biopharmadive.com |
114 |
9.8K |
| Jacob Bell |
|
biopharmadive.com |
114 |
9.8K |
| sumanthkuluru |
|
pharmaceutical-technology.com |
99 |
590 |
| Darcy Jimenez |
|
pharmaceutical-technology.com |
98 |
590 |
| Lei Lei Wu |
|
endpts.com |
83 |
10.9K |
| srinivasmangipudi |
|
pharmaceutical-technology.com |
77 |
590 |
| Kristin Jensen |
|
biopharmadive.com |
72 |
9.8K |
| Carmen |
|
pharmaceutical-technology.com |
61 |
590 |
| Chris Lo |
|
pharmaceutical-technology.com |
53 |
590 |
| Miranda McLaren |
|
pharmaceutical-technology.com |
47 |
590 |
| hasini |
|
pharmaceutical-technology.com |
44 |
590 |
| Alex Hoffman |
|
endpts.com |
43 |
10.9K |
| Jonah Comstock |
|
pharmaphorum.com |
36 |
18.6K |
| Amanda Barrell |
|
pharmaphorum.com |
35 |
18.6K |
| Aayushi Pratap |
|
endpts.com |
32 |
10.9K |
| Jessica Hagen |
|
pharmaphorum.com |
30 |
18.6K |
| Manasi Vaidya |
|
pharmaceutical-technology.com |
29 |
590 |
| Giacomo Lee |
|
pharmaceutical-technology.com |
28 |
590 |
| Ben Hargreaves |
|
pharmaphorum.com |
26 |
18.6K |
| Eloise McLennan |
|
pharmaphorum.com |
26 |
18.6K |
| vbandhakavi |
|
pharmaceutical-business-review.com |
26 |
|
| Shoshana Dubnow |
|
biopharmadive.com |
25 |
9.8K |
| Delilah Alvarado |
|
biopharmadive.com |
24 |
9.8K |
| Nikki Thompson |
|
pharmaceutical-technology.com |
24 |
590 |
| mike.smith@pharmaphorum.com |
|
pharmaphorum.com |
23 |
18.6K |
| Reynald Castaneda |
|
pharmaceutical-technology.com |
21 |
590 |
| Dominic Tyer |
|
pharmaphorum.com |
19 |
18.6K |
| Joy Persaud |
|
pharmaphorum.com |
18 |
18.6K |
| Hasini Devarasetti |
|
pharmaceutical-technology.com |
16 |
590 |
| Adam Zamecnik |
|
pharmaceutical-technology.com |
15 |
590 |
| juliet martin |
|
pharmaceutical-technology.com |
14 |
590 |
| William Newton |
|
pharmaceutical-technology.com |
14 |
590 |
| Alexander Love |
|
pharmaceutical-technology.com |
13 |
590 |
| Nat Schaefer |
|
pharmaceutical-technology.com |
13 |
590 |
| Jack Reinsfield |
|
pharmaphorum.com |
12 |
18.6K |
| Patrick Scott |
|
pharmaceutical-technology.com |
12 |
590 |
| Saywah Mahmood |
|
pharmaceutical-technology.com |
12 |
590 |
| Christopher Newman |
|
biopharmadive.com |
11 |
9.8K |
| Endpoints Staff |
|
endpts.com |
11 |
10.9K |
| Paul Tunnah |
|
pharmaphorum.com |
11 |
18.6K |
| Krishna Chaitanya |
|
pharmaceutical-technology.com |
10 |
590 |
| Lesley Gordon |
|
pharmaphorum.com |
10 |
18.6K |
| natschaefer |
|
pharmaceutical-technology.com |
10 |
590 |
| Nikisha Galoria |
|
pharmaphorum.com |
10 |
18.6K |
| Oliver Stohlmann |
|
pharmaphorum.com |
10 |
18.6K |
| Andrew Hillman |
|
pharmaceutical-technology.com |
9 |
590 |
| Ben Fidler and Ned Pagliarulo |
|
biopharmadive.com |
9 |
9.8K |
| Julian Turner |
|
pharmaceutical-technology.com |
9 |
590 |
| Michael Goodier |
|
pharmaceutical-technology.com |
9 |
590 |
| Felicia Brecher |
|
pharmaphorum.com |
8 |
18.6K |
| Leela Barham |
|
pharmaphorum.com |
8 |
18.6K |
| Saleem Khawaja |
|
pharmaceutical-technology.com |
8 |
590 |
| Srivani Venna |
|
pharmaceutical-technology.com |
8 |
590 |
| Abi Millar |
|
pharmaceutical-technology.com |
7 |
590 |
| fredheritage |
|
pharmaceutical-technology.com |
7 |
590 |
| Irena Maragkou |
|
pharmaceutical-technology.com |
7 |
590 |
| outsourcing-pharma.com |
|
outsourcing-pharma.com |
7 |
10.2K |
| Rebecca Pifer |
|
biopharmadive.com |
7 |
9.8K |
| Richard Jones |
|
pharmaphorum.com |
7 |
18.6K |
| ssapal@smi-online.co.uk |
|
pharmaphorum.com |
7 |
18.6K |
| Beth Bulik |
|
endpts.com |
6 |
10.9K |
| Divya Tirumalaraju |
|
pharmaceutical-technology.com |
6 |
590 |
| Kezia Parkins |
|
pharmaceutical-technology.com |
6 |
590 |
| Fishawack Marketing |
|
pharmaphorum.com |
5 |
18.6K |
| jenna.warren@hansonwade.com |
|
pharmaphorum.com |
5 |
18.6K |
| kalyanjoshi |
|
pharmaceutical-technology.com |
5 |
590 |
| Katrina Megget |
|
pharmaphorum.com |
5 |
18.6K |
| omabuwa.tetsola@systemanalytic.com |
|
pharmaphorum.com |
5 |
18.6K |
| Samantha Liss |
|
biopharmadive.com |
5 |
9.8K |
| Sofia Karadima |
|
pharmaceutical-technology.com |
5 |
590 |
| Chloe Kent |
|
pharmaceutical-technology.com |
4 |
590 |
| Denis Ilinov |
|
pharmaceutical-technology.com |
4 |
590 |
| Glenn Barklie |
|
pharmaceutical-technology.com |
4 |
590 |
| Gwendolyn Wu |
|
biopharmadive.com |
4 |
9.8K |
| isabella hunter |
|
pharmaphorum.com |
4 |
18.6K |
| Jessica Durston |
|
pharmaphorum.com |
4 |
18.6K |
| Jonathan Gardner and Ben Fidler |
|
biopharmadive.com |
4 |
9.8K |
| Katie Wong |
|
pharmaceutical-technology.com |
4 |
590 |
| Ned Pagliarulo and Ben Fidler |
|
biopharmadive.com |
4 |
9.8K |
| Ned Pagliarulo and Jonathan Gardner |
|
biopharmadive.com |
4 |
9.8K |
| Sumanth Kuluru |
|
pharmaceutical-technology.com |
4 |
590 |
| Aninda Chakraborty |
|
pharmaceutical-technology.com |
3 |
590 |
| Annaliese Watkins |
|
pharmaceutical-technology.com |
3 |
590 |
| Ben Fidler, Ned Pagliarulo and Jacob Bell |
|
biopharmadive.com |
3 |
9.8K |
| Catherine McNulty |
|
pharmaphorum.com |
3 |
18.6K |
| Elise Reuter |
|
biopharmadive.com |
3 |
9.8K |
| Erin Thomas |
|
pharmaphorum.com |
3 |
18.6K |
| Hollie Bulfin |
|
pharmaphorum.com |
3 |
18.6K |
| Marina Leiva |
|
pharmaceutical-technology.com |
3 |
590 |
| Milena Izmirlieva |
|
pharmaceutical-technology.com |
3 |
590 |
| Robert Scammell |
|
pharmaceutical-technology.com |
3 |
590 |
| samuel peploe-williams |
|
pharmaphorum.com |
3 |
18.6K |
| Sarah Cohen |
|
endpts.com |
3 |
10.9K |
| Urtė Fultinavičiūtė |
|
pharmaceutical-technology.com |
3 |
590 |
| Akosua Mireku |
|
pharmaceutical-technology.com |
2 |
590 |
| Anne-Charlotte Ackermann |
|
pharmaceutical-technology.com |
2 |
590 |
| Arsalan Arif |
|
endpts.com |
2 |
10.9K |
| Ben Fidler and Jonathan Gardner |
|
biopharmadive.com |
2 |
9.8K |
| Derek Graf |
|
endpts.com |
2 |
10.9K |
| Ellie Saunders |
|
pharmaphorum.com |
2 |
18.6K |
| ellikarampela |
|
pharmaceutical-technology.com |
2 |
590 |
| Eloise Mclennan |
|
pharmaceutical-technology.com |
2 |
590 |
| ENDPOINTS |
|
endpts.com |
2 |
10.9K |
| Endpoints Contributor |
|
endpts.com |
2 |
10.9K |
| Fi Forrest |
|
pharmaceutical-technology.com |
2 |
590 |
| Floriane Reinaud |
|
pharmaceutical-technology.com |
2 |
590 |
| GlobalData |
|
pharmaceutical-technology.com |
2 |
590 |
| Hailey Mensik |
|
biopharmadive.com |
2 |
9.8K |
| Healthware International |
|
pharmaphorum.com |
2 |
18.6K |
| Jacob Bell and Ned Pagliarulo |
|
biopharmadive.com |
2 |
9.8K |
| Jared Whitlock |
|
endpts.com |
2 |
10.9K |
| jasonluff |
|
pharmaceutical-technology.com |
2 |
590 |
| Jonathan Gardner and Jacob Bell |
|
biopharmadive.com |
2 |
9.8K |
| Kathleen Marsh |
|
pharmaceutical-technology.com |
2 |
590 |
| katie jacobs |
|
pharmaphorum.com |
2 |
18.6K |
| Lara Williams |
|
pharmaceutical-technology.com |
2 |
590 |
| Martina Fiore |
|
pharmaphorum.com |
2 |
18.6K |
| Ned Pagliarulo and Jacob Bell |
|
biopharmadive.com |
2 |
9.8K |
| Praveen |
|
pharmaceutical-technology.com |
2 |
590 |
| Ricky Zipp |
|
biopharmadive.com |
2 |
9.8K |
| Sam Duke |
|
pharmaceutical-technology.com |
2 |
590 |
| samduke |
|
pharmaceutical-technology.com |
2 |
590 |
| Serena Pickford Phimmai |
|
pharmaphorum.com |
2 |
18.6K |
| Susanne Hauner |
|
pharmaceutical-technology.com |
2 |
590 |
| timthomas |
|
pharmaceutical-technology.com |
2 |
590 |
| yuliya.pe@bgs.group |
|
pharmaphorum.com |
2 |
18.6K |
| Adam Williams |
|
pharmaceutical-technology.com |
1 |
590 |
| adamleach |
|
pharmaceutical-technology.com |
1 |
590 |
| Alexandra H. Heussner, Ph. D., Laboratory Manager |
|
biopharmadive.com |
1 |
9.8K |
| alexandra@pmsociety.org.uk |
|
pharmaphorum.com |
1 |
18.6K |
| Alvaro Arjona |
|
pharmaceutical-technology.com |
1 |
590 |
| Andrew Burkus, Principal, Omnichannel Marketing, I |
|
biopharmadive.com |
1 |
9.8K |
| Anne Charlotte Ackermann |
|
pharmaceutical-technology.com |
1 |
590 |
| Anushri Shukla |
|
pharmaceutical-technology.com |
1 |
590 |
| Archana Rani |
|
pharmaceutical-technology.com |
1 |
590 |
| Ben Fidler, Jonathan Gardner, Jacob Bell, Ned Pagl |
|
biopharmadive.com |
1 |
9.8K |
| Ben Fidler, Kristin Jensen |
|
biopharmadive.com |
1 |
9.8K |
| Ben Fidler, Shoshana Dubnow and Jonathan Gardner |
|
biopharmadive.com |
1 |
9.8K |
| BioPharma Dive's studioID |
|
biopharmadive.com |
1 |
9.8K |
| Brendan Melck |
|
pharmaceutical-technology.com |
1 |
590 |
| Brian Fitzgerald |
|
pharmaphorum.com |
1 |
18.6K |
| Cyrus Fan |
|
pharmaceutical-technology.com |
1 |
590 |
| Darcy Hodge |
|
pharmaphorum.com |
1 |
18.6K |
| Dave Keating |
|
pharmaceutical-technology.com |
1 |
590 |
| David Lee, Global Therapeutic Area Head, Immunolog |
|
biopharmadive.com |
1 |
9.8K |
| dhorilyk@drug-card.io |
|
pharmaphorum.com |
1 |
18.6K |
| Dr. Dennis Deruelle |
|
biopharmadive.com |
1 |
9.8K |
| Dr. Teena Chopra |
|
biopharmadive.com |
1 |
9.8K |
| Emil Filipov |
|
pharmaceutical-technology.com |
1 |
590 |
| Emily Birt |
|
pharmaphorum.com |
1 |
18.6K |
| Emily Harrison |
|
pharmaphorum.com |
1 |
18.6K |
| Eric Johansson |
|
pharmaceutical-technology.com |
1 |
590 |
| Fiona Barry |
|
pharmaceutical-technology.com |
1 |
590 |
| First Republic Bank |
|
biopharmadive.com |
1 |
9.8K |
| GlobalData Technology |
|
pharmaceutical-technology.com |
1 |
590 |
| Hussein Pirbhai, Operations Director for UK and Eu |
|
biopharmadive.com |
1 |
9.8K |
| Hywel Evans, Director, IQVIA NLP Insights Hub |
|
biopharmadive.com |
1 |
9.8K |
| Isabeau van Halm |
|
pharmaceutical-technology.com |
1 |
590 |
| jade faulkner |
|
pharmaphorum.com |
1 |
18.6K |
| Janet Beal |
|
pharmaceutical-technology.com |
1 |
590 |
| Jason Zemcik, Vice President, Patient Affordabilit |
|
biopharmadive.com |
1 |
9.8K |
| Jennifer Smith |
|
pharmaceutical-technology.com |
1 |
590 |
| Jennifer Smith-Parker |
|
pharmaceutical-technology.com |
1 |
590 |
| Jessica Paulus, ScD, Senior Director, Epidemiology |
|
biopharmadive.com |
1 |
9.8K |
| John Eichert, Senior Principal, Thought Leader Net |
|
biopharmadive.com |
1 |
9.8K |
| Jon Whiteaker |
|
pharmaceutical-technology.com |
1 |
590 |
| Jonathan Gardner and Ned Pagliarulo |
|
biopharmadive.com |
1 |
9.8K |
| Jonathan Gardner and Shoshana Dubnow |
|
biopharmadive.com |
1 |
9.8K |
| Joseph Zabinski, PhD Senior Director, AI and Preci |
|
biopharmadive.com |
1 |
9.8K |
| Kate Keightley |
|
pharmaphorum.com |
1 |
18.6K |
| Kathryn Grimshaw |
|
biopharmadive.com |
1 |
9.8K |
| Leandro Moreira, Yourway |
|
biopharmadive.com |
1 |
9.8K |
| Lewis Page |
|
pharmaceutical-technology.com |
1 |
590 |
| Lizelotte Edvinsson |
|
pharmaphorum.com |
1 |
18.6K |
| MarketLine |
|
pharmaceutical-technology.com |
1 |
590 |
| Matt Leonard |
|
biopharmadive.com |
1 |
9.8K |
| Maura Webber Sadovi |
|
biopharmadive.com |
1 |
9.8K |
| Meredith Cohen |
|
pharmaphorum.com |
1 |
18.6K |
| Molly Sullivan |
|
pharmaphorum.com |
1 |
18.6K |
| Monica Mojumder Chan |
|
pharmaphorum.com |
1 |
18.6K |
| Ned Pagliarulo, Jonathan Gardner and Jacob Bell |
|
biopharmadive.com |
1 |
9.8K |
| oonagh |
|
pharmaphorum.com |
1 |
18.6K |
| Peter Nilson |
|
pharmaceutical-technology.com |
1 |
590 |
| ppconnwpadmin |
|
pharmaphorum.com |
1 |
18.6K |
| prarthnatiga |
|
pharmaceutical-technology.com |
1 |
590 |
| Rhianna Price |
|
pharmaphorum.com |
1 |
18.6K |
| Ricky Zipp and Greg Slabodkin |
|
biopharmadive.com |
1 |
9.8K |
| Riya Binil, Scientific Leader, Cell Biology |
|
biopharmadive.com |
1 |
9.8K |
| Robert Cartee, Ph.D., Senior Director Biopharmaceu |
|
biopharmadive.com |
1 |
9.8K |
| Rosie Andre |
|
pharmaphorum.com |
1 |
18.6K |
| Sarah Rowlands |
|
pharmaphorum.com |
1 |
18.6K |
| Scarlett Evans |
|
pharmaceutical-technology.com |
1 |
590 |
| Sebastian Shehadi |
|
pharmaceutical-technology.com |
1 |
590 |
| Shannon Muchmore |
|
biopharmadive.com |
1 |
9.8K |
| Sophia Devi |
|
pharmaceutical-technology.com |
1 |
590 |
| ssaib@vwv.co.uk |
|
pharmaphorum.com |
1 |
18.6K |
| Stefan Weiss, MD, MHSc, MBA, Managing Director of |
|
biopharmadive.com |
1 |
9.8K |
| Susan Kelly |
|
biopharmadive.com |
1 |
9.8K |
| Viola Caon |
|
pharmaceutical-technology.com |
1 |
590 |
| Wa’el Hashad, President and CEO, Avanir Pharmaceut |
|
biopharmadive.com |
1 |
9.8K |
| Yena Patel, Sahil Shah and Bart Byczynski |
|
biopharmadive.com |
1 |
9.8K |
